| [1] |
Starzl TE, Zinkernagel RM. Transplantation tolerance from a historical perspective. Nat Rev Immunol, 2001,1:233-239.
|
| [2] |
Birkeland SA, Hamilton-Dutoit S. Is posttransplant lymphopro- liferative disorder (PTLD) caused by any specific immunosup- pressive drug or by the transplantation per se Transplantation, 2003, 76:984-988.
|
| [3] |
Feng S, Ekong UD, Lobritto SJ, et al. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of paren- tal living donor liver transplants. JAMA, 2012, 307: 283-293.
|
| [4] |
Horst AK, Neumann K, Diehl L, et al. Modulationoflivertoler- ance by conventional and nonconventional antigen-presenting cells and regulatory immune cells. Cell Mol Immunol, 2016, 13: 277-292.
|
| [5] |
Adams DH, Sanchez-Fueyo A, Samuel D. From immunosup- pression to tolerance. J Hepatol, 2015, 62(1 Suppl):S170-S185.
|
| [6] |
Bohne F, Londono MC, Benitez C, et al. HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans. Sci Transl Med, 2014, 6: 242ra281.
|
| [7] |
Hubscher SG, Adams DH, Elias E. Changes in the expression of major histocompatibility complex class II antigens in liver allo- graft rejection. J Pathol, 1990, 162: 165-171.
|
| [8] |
Manzia TM, Angelico R, Baiocchi L, et al. The Tor Vergata weaning of immunosuppression proto- cols in stable hepatitis C virus liver transplant patients: the 10- year follow-up. Transpl Int, 2013, 26: 259-266.
|
| [9] |
Yoshitomi M, Koshiba T, Haga H, et al. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation. Transplantation, 2009, 87: 606-614.
|
| [10] |
Feng S, Demetris AJ, Spain KM, et al. Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R. Hepatology, 2017, 65: 647-660.
|
| [11] |
Crispe IN. Immune tolerance in liver disease. Hepatology, 2014, 60: 2109-2117.
|
| [12] |
Steger U, Denecke C, Sawitzki B, et al. Exhaustive differentiation of alloreactive CD81 T cells: criti- cal for determination of graft acceptance or rejection. Transplan- tation, 2008, 85: 1339-1347.
|
| [13] |
Li W, Kuhr CS, Zheng XX, et al. New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD251CD41 regulatory T cells. Am J Transplant, 2008, 8: 1639-1651.
|
| [14] |
Morris H, DeWolf S, Robins H, et al. Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients. Sci Transl Med, 2015, 7: 272ra210.
|
| [15] |
LoCascio SA, Morokata T, Chittenden M, et al. Mixed chimerism, lympho- cyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplan- tation to induce tolerance. Transplantation, 2010, 90: 1607-1615.
|
